Improving Bone Marrow Transplant Outcomes with Educational Sleep Intervention

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness and safety of an educational sleep intervention compared to standard care for adults undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). It involves randomizing eligible patients to receive either the app-based educational intervention or standard care. The study aims to enhance patient outcomes by providing tailored educational resources to improve sleep quality during the transplant process. Screening and randomization will occur in the patient's home environment to facilitate participation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or female patients aged 18 or older at the time of study informed consent.
* Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
* Patients have access to digital device capable of downloading study app
* Patients able to read study documents and able to complete informed consent within the study app

Exclusion Criteria:

* Failed prior alloHSCT within the past 6 months

Where it's running

• Scripps Health
  San Diego, California, United States Recruiting

Study contacts

• Principal investigator: Jake New, MD, PhD — Scripps Clinic
• Study coordinator: Jake New, MD, PhD
• Email: new.jacob@scrippshealth.org
• Phone: 858-784-2701

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How iNKT immune cells after allogeneic stem cell transplant relate to transplant complications

  This study tests whether levels of invariant NKT cells in the blood after an allogeneic stem cell transplant can be linked to complications like GvHD, infections, or relapse in patients with AML.

  Recruiting University Hospital Pilsen · Pilsen, Czechia · NCT07570407

• Psychiatric Symptoms and Quality of Life in Graft-versus-Host Disease

  This project will see if psychiatric symptoms like depression are linked to GvHD symptom severity and health-related quality of life in adults with graft-versus-host disease.

  Recruiting Medical University of Gdansk · Gdansk, Pomeranian Voivodeship · NCT07314892

• Early Tacrolimus Taper After Allogeneic Transplant

  This study tests whether stopping tacrolimus early after an allogeneic stem cell transplant is safe and feasible for people with AML, MDS, MF, CML, CMML, or GVHD risk after transplant.

  Recruiting Phase 1 Stanford University · Palo Alto, California · NCT07302776

• Vorinostat to help prevent GVHD in young people with non-malignant conditions undergoing stem cell transplant

  This phase 2 study tests whether adding vorinostat to standard GVHD prevention can reduce GVHD after stem cell transplant in patients aged 1–26 with non-malignant disorders.

  Recruiting Phase 2 University of Michigan · Ann Arbor, Michigan · NCT06995521

• Group telehealth program to help adults with chronic graft-versus-host disease

  This program tests whether the HORIZONS group telehealth sessions help adults with moderate to severe chronic graft-versus-host disease manage symptoms and improve quality of life compared with usual care.

  Recruiting at 2 sites Massachusetts General Hospital · Miami, Florida and 1 other locations · NCT06910969

• Digital application to improve sexual health for stem cell transplant survivors

  This study is testing a new app to help survivors of stem cell transplants improve their sexual health and overall well-being.

  Recruiting Massachusetts General Hospital · Coral Gables, Florida and 2 other locations · NCT06541002

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.